Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Ticagrelor 90 mg tablets in healthy Thai volunteers under fasting
TCTR20170523002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ticagrelor (2 arms), sponsored by Bio-innova. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
ticagrelor
Beyond the preview
Go deeper on TCTR20170523002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170523002.